Michael Forer - 11 Aug 2026 Form 4 Insider Report for GH Research PLC (GHRS)

Reporting relationship: Director
Issuer ticker: GHRS
Reported as of: 11 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Aug 2026, 16:41:45 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Forer

Key filing fact

Michael Forer filed Form 4 for GH Research PLC (GHRS) on 13 Aug 2026.

Key facts

This page summarizes Michael Forer's Form 4 filing for GH Research PLC (GHRS).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 13 Aug 2026, 16:41.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002126827 Primary reporting owner

Forer Michael

Relationship: Director
Address: C/O GH RESEARCH PLC, JOSHUA DAWSON HOUSE, DAWSON STREET, DUBLIN, IRELAND
Signature: /s/ Michael Forer
Signature date: 13 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GHRS transaction Derivative

Share Options (Right to Buy)

Award

Transaction value
Shares: +2,202
Change %
Price: $0.000000^*
Shares after: 2,202
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,202
Exercise price: $0.0250
Footnotes: F1

GHRS transaction Derivative

Share Options (Right to Buy)

Award

Transaction value
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 100,000
Date: 11 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 100,000
Exercise price: $0.0250
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The share options are immediately fully vested, but are not exercisable until August 11, 2028.

Footnote F2

The share options vest and become exercisable with respect to 25% on August 11, 2027 and with respect to the remaining 75% in equal monthly installments for three years thereafter.